Hugosson, J.

cancer screening prostate prostate cancer study biopsy round control arm group erspc result control treatment interval european randomized study european centre mortality trial incidence follow-up rotterdam cohort number patient randomized diagnosis detection screening arm sweden antigen death analysis netherland center table model finland disease value roobol effect gleason screening round interval cancers urology university difference therapy velocity score psa level outcome characteristic level psa velocity prostate cancer screening roobol mj prostate biopsy stage sensitivity reduction gothenburg screening interval schr öder fh surveillance rp group schroder control group journal screening rounds contamination grade lead-time population management european randomised study screen cancer detection rate prostate-speci fic antigen